LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Search

Quest Diagnostics Inc

Suletud

SektorTervishoid

179.09 1.52

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

178.22

Max

179.32

Põhinäitajad

By Trading Economics

Sissetulek

-37M

259M

Müük

55M

2.8B

P/E

Sektori keskmine

21.015

77.256

Dividenditootlus

1.79

Kasumimarginaal

9.197

Töötajad

45,000

EBITDA

96M

547M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+12.37% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.79%

2.33%

Turustatistika

By TradingEconomics

Turukapital

-1.4B

20B

Eelmine avamishind

177.57

Eelmine sulgemishind

179.09

Uudiste sentiment

By Acuity

55%

45%

297 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Quest Diagnostics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. nov 2025, 21:06 UTC

Suurimad hinnamuutused turgudel

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8. nov 2025, 18:10 UTC

Tulu

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8. nov 2025, 13:10 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8. nov 2025, 12:00 UTC

Tulu

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8. nov 2025, 10:30 UTC

Tulu

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8. nov 2025, 03:50 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8. nov 2025, 03:41 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8. nov 2025, 03:07 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7. nov 2025, 22:36 UTC

Tulu

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7. nov 2025, 22:22 UTC

Tulu

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q Rev $2.95B >CSU.T

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q Net $210M >CSU.T

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q EPS $9.89 >CSU.T

7. nov 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7. nov 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7. nov 2025, 20:59 UTC

Tulu

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7. nov 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7. nov 2025, 20:22 UTC

Tulu

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7. nov 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7. nov 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7. nov 2025, 19:31 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7. nov 2025, 19:17 UTC

Tulu

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7. nov 2025, 19:09 UTC

Tulu

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7. nov 2025, 19:08 UTC

Tulu

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7. nov 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7. nov 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Quest Diagnostics Inc Prognoos

Hinnasiht

By TipRanks

12.37% tõus

12 kuu keskmine prognoos

Keskmine 201.7 USD  12.37%

Kõrge 215 USD

Madal 190 USD

Põhineb 11 Wall Streeti analüütiku instrumendi Quest Diagnostics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

4

Osta

7

Hoia

0

Müü

Tehniline skoor

By Trading Central

175.87 / 176.5Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

297 / 374 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
help-icon Live chat